Announcements Trials
Browse Landscape

Phase

Phase NA 56Phase 2 6Phase 4 2Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Tobacco Use Cessation 1Smoking Cessation 1Sexuality 1Pleural Effusion, Malignant 1Neuroendocrine Tumors 1Gastrointestinal Neoplasms 1Acute Pain 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Surveys and Questionnaires × Clear all
NCT07490509 2026-04-01

DOSABEMA

Poitiers University Hospital

Phase 4 Not yet recruiting
235 enrolled
Breast

Breast Neoplasms

NCT02502864 2020-09-11

Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

H. Lee Moffitt Cancer Center and Research Institute

Phase 4 Completed
9 enrolled 9 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡